|
Brief Reports
Citations 401-410 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Sorafenib is a potent inhibitor of FIP1L1-PDGFR and the imatinib-resistant FIP1L1-PDGFR T674I mutant
- Els Lierman, Cedric Folens, Elizabeth H. Stover, Nicole Mentens, Helen Van Miegroet, Werner Scheers, Marc Boogaerts, Peter Vandenberghe, Peter Marynen, and Jan Cools
Blood 2006; 108: 1374-1376.
[Abstract]
[Full text]
[PDF]
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
- Robert Kralovics, Soon-Siong Teo, Sai Li, Alexandre Theocharides, Andreas S. Buser, Andre Tichelli, and Radek C. Skoda
Blood 2006; 108: 1377-1380.
[Abstract]
[Full text]
[PDF]
Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis
- Jeanne-Claire Lesbordes-Brion, Lydie Viatte, Myriam Bennoun, Dan-Qing Lou, Guillemette Ramey, Christophe Houbron, Ghislaine Hamard, Axel Kahn, and Sophie Vaulont
Blood 2006; 108: 1402-1405.
[Abstract]
[Full text]
[PDF]
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation–related imatinib failure
- Elias Jabbour, Jorge Cortes, Hagop M. Kantarjian, Sergio Giralt, Dan Jones, Roy Jones, Francis Giles, Borje S. Andersson, Richard Champlin, and Marcos de Lima
Blood 2006; 108: 1421-1423.
[Abstract]
[Full text]
[PDF]
Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice
- Byeong-Chel Lee, Shalom Avraham, Akira Imamoto, and Hava Karsenty Avraham
Blood 2006; 108: 904-907.
[Abstract]
[Full text]
[PDF]
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIb antibodies
- Michelle Lee Webster, Ebrahim Sayeh, Min Crow, Pingguo Chen, Bernhard Nieswandt, John Freedman, and Heyu Ni
Blood 2006; 108: 943-946.
[Abstract]
[Full text]
[PDF]
Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma
- Marko Pesu, Linda Muul, Yuka Kanno, and John J. O'Shea
Blood 2006; 108: 983-985.
[Abstract]
[Full text]
[PDF]
FVIII production by human lung microvascular endothelial cells
- Marc Jacquemin, Arne Neyrinck, Maria Iris Hermanns, Renaud Lavend'homme, Filip Rega, Jean-Marie Saint-Remy, Kathelijne Peerlinck, Dirk Van Raemdonck, and Charles James Kirkpatrick
Blood 2006; 108: 515-517.
[Abstract]
[Full text]
[PDF]
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
- David H. Chang, Nancy Liu, Virginia Klimek, Hani Hassoun, Amitabha Mazumder, Stephen D. Nimer, Sundar Jagannath, and Madhav V. Dhodapkar
Blood 2006; 108: 618-621.
[Abstract]
[Full text]
[PDF]
The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH)
- David J. Araten and Lucio Luzzatto
Blood 2006; 108: 734-736.
[Abstract]
[Full text]
[PDF]
|
|
